Developer docs
API playgroundTry for free, no card

Search company profiles

Cureety

Full company profile

uuid00025yz

Namestring
Cureety
Legal namestring
Cureety SAS
Websiteurl
cureety.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Cureety SAS is a French digital health company, headquartered in Dinan, France, that builds an oncology-specialized remote patient monitoring and care coordination platform. The platform converts patient-reported symptoms into CTCAE v6.0-graded clinical intelligence layered against the patient's specific treatment regimen, cancer type, and history, enabling cancer centers and hospitals to triage critical signals earlier and with less alert fatigue. Its two core modules — Precision Patient Monitoring and Precision Care Management — are supported by a free patient and caregiver app (iOS, Android, web) and a Scientific Committee drawing oncologists from institutions including Gustave Roussy, MD Anderson, Moffitt, Yale, and City of Hope.

The company's technology backbone is a therapy-specific triage algorithm validated with 95.8% sensitivity and 94.4% specificity over 400+ patients (ASCO 2023) and benchmarked to generate roughly 60% fewer red alerts than PRO-CTCAE-based systems across 2.46 million adverse events (Argos II 2026). Care Management extends the platform into automated treatment calendars, infusion readiness checks that integrate labs and patient-reported toxicity, adherence monitoring, and automated billing documentation for U.S. Remote Therapeutic Monitoring (RTM), Chronic Care Management (CCM), and Principal Illness Navigation (PIN) codes. The platform syncs with existing EHR infrastructure and holds HIPAA, ISO 13485, and ISO 27001 certifications.

Cureety sells primarily on a subscription basis to hospitals, cancer centers, and oncology departments via direct enterprise sales, supported by scientific-committee endorsements and partnerships with AVBCC, ACCC, NCODA, and Judi. Customers cited include AP-HP, CHU de Lyon, CHU de Montpellier, CHU Saint-Etienne, CHU Reims, CHRU Tours, Institut Godinot, Centre François Baclesse, CH Dunkerque, and Portuguese operator Hospital Cálice (Lusiadas Saude). Pricing is quote-based and not publicly disclosed; the patient app is free and distributed only via healthcare-provider prescription. As of the January 2022 funding round (€5M led by French mutual insurers with Bpifrance), the company had supported over 70,000 patients and 3,500+ healthcare professionals across 250+ cancer centers globally and was planning an office in Italy as part of European expansion.

Short descriptiontext

Cureety SAS is a French digital health company that provides an oncology-specialized remote patient monitoring and care coordination platform to hospitals and cancer centers, using a therapy-specific triage algorithm that converts patient-reported symptoms into CTCAE-graded clinical intelligence to detect toxicity earlier and reduce hospitalizations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology remote monitoring, telemedicine platform, digital health software, cancer care management, clinical intelligence platform
Industry3 codes
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALABAK
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
SECONDARYHLALACAE
Chronic Condition Virtual Care & Disease Management (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Oncology Remote Patient Monitoring Software
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Healthcare Institution Subscriptions
TypeSubscription Recurring
Description

Cureety provides its remote monitoring platform to healthcare institutions including cancer centers and hospitals on a subscription basis. The platform enables remote therapeutic monitoring (RTM), chronic care management (CCM), and principal illness navigation (PIN) billing.

atlanpolebiotherapies.eu
2Patient App (Free for Patients)
TypeSubscription Recurring
Description

The Cureety patient app is provided free of charge to patients, prescribed by healthcare providers. Revenue is generated through healthcare institution subscriptions, not direct patient billing.

cureety.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Free patient app prescribed by healthcare providers
ModelFreemiumBilling cadenceMonthly
Notes

$0 for patients. Available by prescription. Compatible with phone, tablet, or computer via web app and mobile apps (iOS and Google Play).

cureety.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Cureety provides an oncology-specialized remote monitoring platform that transforms patient-reported symptoms into CTCAE-graded, therapy-specific clinical intelligence for cancer care teams. The platform comprises Precision Patient Monitoring and Precision Care Management modules, plus a free Cureety App for patients and caregivers, enabling proactive intervention, treatment readiness checks, and care coordination between clinic visits.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 61% reduction in hospitalization stays through proactive toxicity detection
+8 more records
Product overview1 text field

Cureety offers a unified oncology precision care platform comprising two core modules — Precision patient monitoring and Precision care Management — plus a patient-facing Cureety App. The platform is built on therapy-specific algorithms that map patient-reported symptoms directly to CTCAE grades, enabling intelligent triage that differentiates critical signals from routine side effects based on the patient's specific treatment regimen, cancer type, and clinical history. Precision patient monitoring handles remote symptom monitoring and early risk detection, while Precision care Management orchestrates treatment calendars, infusion readiness checks, adherence monitoring, and billing documentation. Both modules share a unified intelligence layer and connect to EHR systems via built-in sync.

Product and service3 records
1Precision Patient Monitoring
CategoryRemote Patient Monitoring Software
Description

Oncology-specialized remote monitoring module that transforms patient-reported symptoms into CTCAE-graded, therapy-specific triage intelligence. Uses validated algorithms to detect critical signals early and reduce alert fatigue by 60% versus PRO-CTCAE based systems. Designed for oncology care teams at cancer centers and hospitals.

2Precision Care Management
CategoryCare Coordination Software
Description

Care coordination and workflow management module that automates treatment calendars, treatment readiness checks integrating lab results with patient toxicity reports, treatment adherence monitoring, and billing documentation (RTM, CCM, PIN). Connects the entire oncology care team in one orchestrated system. Designed for clinicians and care teams at cancer centers.

3Cureety App
CategoryPatient-facing Application
Description

Free patient and caregiver mobile and web application for daily symptom reporting, treatment guidance, appointment reminders, and secure communication with care teams. Prescribed by healthcare providers and provided free of charge to oncology patients.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Listed as Expert Partner in Cureety's strategic partner network. Judi provides expertise in oncology digital health solutions.

2AVBCC (Advanced Vaginal & Bladder Cancer Consortium - Association of Value-Based Cancer Care)
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Listed as Scientific Association partner. AVBCC is a scientific association focused on value-based cancer care, aligning with Cureety's mission.

cureety.com
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Listed as strategic partner. ACCC represents community cancer centers, providing a network for Cureety's oncology monitoring platform.

4NCODA
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Listed as strategic partner. NCODA is an organization supporting oral chemotherapy and oncology care, aligning with Cureety's treatment adherence monitoring capabilities.

cureety.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Remote patient monitoring and virtual care platform with oncology as one of its target conditions. Smaller and more generalist than Cureety but addresses similar use cases of symptom tracking, care coordination, and EHR integration for cancer patients.

TypeBroad incumbent
Description

Established remote patient monitoring platform supporting multiple chronic conditions including oncology-adjacent use cases. Broader and therapy-agnostic compared with Cureety, but competes for the same RPM budgets in large health systems.

TypeDirect peer
Description

Direct competitor in oncology-specific patient-reported outcomes and remote symptom monitoring. Originally Finnish, acquired by Elekta in 2021, Kaiku Health serves cancer centers across Europe and globally with a similar therapy-specific monitoring approach, making it Cureety's closest head-to-head competitor.

TypeDirect peer
Description

Oncology patient engagement and symptom management platform originally from Finland, acquired by Varian (now Siemens Healthineers). Targets the same cancer-center customer with PRO-based remote monitoring and is embedded in radiation oncology workflows — a direct overlap with Cureety's oncology RPM offering.

TypeDirect peer
Description

Digital care management platform originally focused on musculoskeletal conditions but expanding into oncology and other specialties with patient-facing remote monitoring and care pathways. Comparable enterprise sales motion and remote monitoring architecture.

6Carevive Systems
TypeDirect peer
Description

US-based oncology remote patient monitoring and care management platform serving cancer centers with symptom tracking, care plans, and patient engagement. Competes for the same institutional oncology customers as Cureety, particularly in the US value-based care market.

TypeBroad incumbent
Description

Oncology-specific electronic health record and real-world evidence platform owned by Roche. Operates broadly in oncology technology with deep US cancer center penetration, and overlaps with Cureety's RWE and clinical decision-support ambitions, though it does not focus on patient-facing symptom monitoring.

8Tempus Labs
TypeBroad incumbent
Description

Large US oncology AI and data company offering molecular profiling, clinical decision support, and real-world evidence. Competes with Cureety in oncology clinical intelligence and pharma RWE, with substantially greater capital and data scale.

TypeDirect peer
Description

US oncology patient platform providing symptom monitoring, care plans, and patient engagement for cancer centers and oncology practices. Directly comparable product offering and customer base to Cureety in the oncology RPM category.

TypeEmerging player
Description

US oncology navigation and care management company that combines human navigators with technology to support cancer patients. Adjacent to Cureety's oncology care management capabilities but with stronger emphasis on human-led navigation and US payer/provider contracting.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cureety

Oncology Remote Patient Monitoring Softwarecureety.com

Cureety SAS is a French digital health company that provides an oncology-specialized remote patient monitoring and care coordination platform to hospitals and cancer centers, using a therapy-specific triage algorithm that converts patient-reported symptoms into CTCAE-graded clinical intelligence to detect toxicity earlier and reduce hospitalizations.

What Cureety does

Cureety SAS is a French digital health company, headquartered in Dinan, France, that builds an oncology-specialized remote patient monitoring and care coordination platform. The platform converts patient-reported symptoms into CTCAE v6.0-graded clinical intelligence layered against the patient's specific treatment regimen, cancer type, and history, enabling cancer centers and hospitals to triage critical signals earlier and with less alert fatigue. Its two core modules — Precision Patient Monitoring and Precision Care Management — are supported by a free patient and caregiver app (iOS, Android, web) and a Scientific Committee drawing oncologists from institutions including Gustave Roussy, MD Anderson, Moffitt, Yale, and City of Hope.

The company's technology backbone is a therapy-specific triage algorithm validated with 95.8% sensitivity and 94.4% specificity over 400+ patients (ASCO 2023) and benchmarked to generate roughly 60% fewer red alerts than PRO-CTCAE-based systems across 2.46 million adverse events (Argos II 2026). Care Management extends the platform into automated treatment calendars, infusion readiness checks that integrate labs and patient-reported toxicity, adherence monitoring, and automated billing documentation for U.S. Remote Therapeutic Monitoring (RTM), Chronic Care Management (CCM), and Principal Illness Navigation (PIN) codes. The platform syncs with existing EHR infrastructure and holds HIPAA, ISO 13485, and ISO 27001 certifications.

Cureety sells primarily on a subscription basis to hospitals, cancer centers, and oncology departments via direct enterprise sales, supported by scientific-committee endorsements and partnerships with AVBCC, ACCC, NCODA, and Judi. Customers cited include AP-HP, CHU de Lyon, CHU de Montpellier, CHU Saint-Etienne, CHU Reims, CHRU Tours, Institut Godinot, Centre François Baclesse, CH Dunkerque, and Portuguese operator Hospital Cálice (Lusiadas Saude). Pricing is quote-based and not publicly disclosed; the patient app is free and distributed only via healthcare-provider prescription. As of the January 2022 funding round (€5M led by French mutual insurers with Bpifrance), the company had supported over 70,000 patients and 3,500+ healthcare professionals across 250+ cancer centers globally and was planning an office in Italy as part of European expansion.

Cureety firmographics

Firmographics
Name
Cureety
Legal name
Cureety SAS
Website
https://cureety.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
101–250 employees
Short description
Cureety SAS is a French digital health company that provides an oncology-specialized remote patient monitoring and care coordination platform to hospitals and cancer centers, using a therapy-specific triage algorithm that converts patient-reported symptoms into CTCAE-graded clinical intelligence to detect toxicity earlier and reduce hospitalizations.
Ownership category
akta.pro rank

Where Cureety is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Cureety business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Healthcare Institution Subscriptions: Cureety provides its remote monitoring platform to healthcare institutions including cancer centers and hospitals on a subscription basis. The platform enables remote therapeutic monitoring (RTM), chronic care management (CCM), and principal illness navigation (PIN) billing.
  2. Patient App (Free for Patients): The Cureety patient app is provided free of charge to patients, prescribed by healthcare providers. Revenue is generated through healthcare institution subscriptions, not direct patient billing.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree patient app prescribed by healthcare providers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Cureety product offering

Product offering

Core offering

Cureety provides an oncology-specialized remote monitoring platform that transforms patient-reported symptoms into CTCAE-graded, therapy-specific clinical intelligence for cancer care teams. The platform comprises Precision Patient Monitoring and Precision Care Management modules, plus a free Cureety App for patients and caregivers, enabling proactive intervention, treatment readiness checks, and care coordination between clinic visits.

Product overview

Cureety offers a unified oncology precision care platform comprising two core modules — Precision patient monitoring and Precision care Management — plus a patient-facing Cureety App. The platform is built on therapy-specific algorithms that map patient-reported symptoms directly to CTCAE grades, enabling intelligent triage that differentiates critical signals from routine side effects based on the patient's specific treatment regimen, cancer type, and clinical history. Precision patient monitoring handles remote symptom monitoring and early risk detection, while Precision care Management orchestrates treatment calendars, infusion readiness checks, adherence monitoring, and billing documentation. Both modules share a unified intelligence layer and connect to EHR systems via built-in sync.

Differentiator

Problem solved

Functional benefit

Products and services

  • Precision Patient Monitoring Oncology-specialized remote monitoring module that transforms patient-reported symptoms into CTCAE-graded, therapy-specific triage intelligence. Uses validated algorithms to detect critical signals early and reduce alert fatigue by 60% versus PRO-CTCAE based systems. Designed for oncology care teams at cancer centers and hospitals.
  • Precision Care Management Care coordination and workflow management module that automates treatment calendars, treatment readiness checks integrating lab results with patient toxicity reports, treatment adherence monitoring, and billing documentation (RTM, CCM, PIN). Connects the entire oncology care team in one orchestrated system. Designed for clinicians and care teams at cancer centers.
  • Cureety App Free patient and caregiver mobile and web application for daily symptom reporting, treatment guidance, appointment reminders, and secure communication with care teams. Prescribed by healthcare providers and provided free of charge to oncology patients.

Quantifiable outcome

  • 61% reduction in hospitalization stays through proactive toxicity detection
  • +8 more outcomes

Companies that use Cureety

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles2 records

Cureety technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature8 records

Cureety partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered supporting.

  • JudisupportingStrategic or Co-development PartnerListed as Expert Partner in Cureety's strategic partner network. Judi provides expertise in oncology digital health solutions.
  • AVBCC (Advanced Vaginal & Bladder Cancer Consortium - Association of Value-Based Cancer Care)supportingStrategic or Co-development PartnerListed as Scientific Association partner. AVBCC is a scientific association focused on value-based cancer care, aligning with Cureety's mission.
  • ACCC (Association of Community Cancer Centers)supportingStrategic or Co-development PartnerListed as strategic partner. ACCC represents community cancer centers, providing a network for Cureety's oncology monitoring platform.
  • NCODAsupportingStrategic or Co-development PartnerListed as strategic partner. NCODA is an organization supporting oral chemotherapy and oncology care, aligning with Cureety's treatment adherence monitoring capabilities.

Scale indicators14 records

Recent moves7 records

Expansion highlights6 records

Cureety competitors and assessment

Company assessment

Emerging players

  • Medocity: Remote patient monitoring and virtual care platform with oncology as one of its target conditions. Smaller and more generalist than Cureety but addresses similar use cases of symptom tracking, care coordination, and EHR integration for cancer patients.
  • Thyme Care: US oncology navigation and care management company that combines human navigators with technology to support cancer patients. Adjacent to Cureety's oncology care management capabilities but with stronger emphasis on human-led navigation and US payer/provider contracting.

Broad incumbents

  • Vivify Health: Established remote patient monitoring platform supporting multiple chronic conditions including oncology-adjacent use cases. Broader and therapy-agnostic compared with Cureety, but competes for the same RPM budgets in large health systems.
  • Flatiron Health: Oncology-specific electronic health record and real-world evidence platform owned by Roche. Operates broadly in oncology technology with deep US cancer center penetration, and overlaps with Cureety's RWE and clinical decision-support ambitions, though it does not focus on patient-facing symptom monitoring.
  • Tempus Labs: Large US oncology AI and data company offering molecular profiling, clinical decision support, and real-world evidence. Competes with Cureety in oncology clinical intelligence and pharma RWE, with substantially greater capital and data scale.

Direct peers

  • Kaiku Health: Direct competitor in oncology-specific patient-reported outcomes and remote symptom monitoring. Originally Finnish, acquired by Elekta in 2021, Kaiku Health serves cancer centers across Europe and globally with a similar therapy-specific monitoring approach, making it Cureety's closest head-to-head competitor.
  • Noona Healthcare: Oncology patient engagement and symptom management platform originally from Finland, acquired by Varian (now Siemens Healthineers). Targets the same cancer-center customer with PRO-based remote monitoring and is embedded in radiation oncology workflows — a direct overlap with Cureety's oncology RPM offering.
  • Force Therapeutics: Digital care management platform originally focused on musculoskeletal conditions but expanding into oncology and other specialties with patient-facing remote monitoring and care pathways. Comparable enterprise sales motion and remote monitoring architecture.
  • Carevive Systems: US-based oncology remote patient monitoring and care management platform serving cancer centers with symptom tracking, care plans, and patient engagement. Competes for the same institutional oncology customers as Cureety, particularly in the US value-based care market.
  • Navigating Cancer: US oncology patient platform providing symptom monitoring, care plans, and patient engagement for cancer centers and oncology practices. Directly comparable product offering and customer base to Cureety in the oncology RPM category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cureety compliance and trust

Trust signal

Compliance3 records

Cureety financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cureety leadership team

Management profile

Number of profiles

Profiles1 record

Cureety funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cureety M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cureety

What does Cureety do?

Cureety provides an oncology-specialized remote monitoring platform that transforms patient-reported symptoms into CTCAE-graded, therapy-specific clinical intelligence for cancer care teams. The platform comprises Precision Patient Monitoring and Precision Care Management modules, plus a free Cureety App for patients and caregivers, enabling proactive intervention, treatment readiness checks, and care coordination between clinic visits.

Is Cureety a public or private company?

Cureety is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cureety founded?

Cureety was founded in 2018. It employs 101 to 250 people.

Where is Cureety based?

Cureety is headquartered in Paris, France, in the Europe region.

How does Cureety make money?

Two revenue lines are on record. Healthcare Institution Subscriptions are the primary driver. The others are patient App (Free for Patients).

Who are Cureety's main competitors?

Emerging players on record are Medocity and Thyme Care. Broad incumbents are Vivify Health, Flatiron Health and Tempus Labs. Direct peers are Kaiku Health, Noona Healthcare, Force Therapeutics, Carevive Systems and Navigating Cancer.

Does Cureety have an API?

No public API is recorded for Cureety.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MobiHealthNewsCureety acquires AI virtual oncology company Reimagine CareCureety acquired Reimagine Care, a Nashville-based virtual oncology platform. The deal integrates Cureety's monitoring and clinical intelligence with Reimagine Care's AI patient engagement and care teams. The acquisition aims to combine European and U.S. oncology care models to address capacity constraints.InvestorsinhealthcareFrance: Cureety acquires Reimagine Care to extend precision oncology care beyond the clinicCureety, a France-based precision oncology care company, acquired Reimagine Care, a US company that combines AI-powered cancer care support with oncology-specialised care teams. The acquisition aims to extend cancer care beyond the clinic.Pulse 2.0Cureety Acquires Reimagine Care To Expand Precision Oncology Care PlatformCureety acquired Reimagine Care, combining therapy-specific oncology monitoring with AI-supported patient engagement. The combined organization supports over 250 cancer centers and 100,000 patients across five countries. The companies plan to build a continuous precision oncology care model for personalized treatments.HIT ConsultantM&A: Cureety Acquires Reimagine Care to Expand Precision Oncology Platform Across 250 Cancer CentersCureety acquired Nashville-based Reimagine Care, combining therapy-specific triage software with conversational AI patient engagement. The combined entity serves over 250 cancer centers and 100,000 patients across five countries with a 150-person workforce. Financial terms were not disclosed.Business Wire BlogCureety Acquires Reimagine Care to Build the Future of Precision Oncology CareCureety acquired Reimagine Care, an AI-powered oncology care organization, to combine therapy-specific monitoring with patient engagement. The combined organization supports over 250 cancer centers and 100,000 patients across five countries. The acquisition aims to extend personalized care beyond scheduled visits.McknightshomecareCureety acquisition of Reimagine Care to provide more cancer care in the homeCureety, a French oncology platform, acquired Reimagine Care, a Nashville-based virtual cancer care provider. The deal will expand therapy-specific home care for American patients, with product roadmaps to be combined over six to 12 months. Reimagine's Remi AI assistant will be brought to Europe, and Cureety's platform to the US.CureetyCureety acquires Reimagine Care to build the future of precision oncology careCureety acquired Reimagine Care, an AI-powered oncology care organization, to combine therapy-specific monitoring with AI-supported patient engagement. The combined organization supports over 250 cancer centers and 100,000 patients across five countries. The companies aim to extend personalized care beyond scheduled visits.ReimaginecareCureety Acquires Reimagine Care to Build the Future of Precision Oncology CareCureety acquired Reimagine Care, an AI-powered oncology care organization, to combine therapy-specific monitoring with patient engagement. The combined organization supports over 250 cancer centers and 100,000 patients across five countries. The deal aims to extend personalized care beyond scheduled visits.FierceHealthcareCureety acquires Reimagine Care for AI-driven precision oncologyCureety acquired Reimagine Care, an AI-driven oncology care organization, on Sept. 2. The combined companies now support over 250 cancer centers and 100,000 patients across five countries. Financial terms were not disclosed.PR NewswireConnecting clinical knowledge with care delivery: NCODA and Cureety partner to bring trusted regimen guidance at the point of careNCODA and Cureety announced a partnership on Aug. 27, 2026 to integrate NCODA's Patient Education Sheets into Cureety's oncology care workflows. The sheets were developed with the ACCC, HOPA and ONS, and aim to give clinicians and patients regimen-specific information, support adherence and toxicity monitoring, and reduce the need to search external resources.